Novotech Launches Early Phase Unit for Biotechs in Australian and New Zealand Clinical Environment

Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and n...

 June 14, 2024 | News

Genetic Signatures Receives FDA Clearance for EasyScreen™ Gastrointestinal Parasite Detection Kit

Genetic Signatures Limited  a global molecular diagnostics company announces that the US Food & Drug Administration ("FDA") has cleared the Compan...

 June 05, 2024 | News

Telix Pharmaceuticals Completes BLA Submission to FDA for Breakthrough Kidney Cancer Imaging Agent TLX250-CDx

Telix Pharmaceuticals announces that it has completed the submission of a Biologics License Application (BLA) to the United States (U.S.) Food an...

 June 03, 2024 | News

LumaCina to Produce Oral Morphine Amidst Critical Shortage in New Zealand

 LumaCina, the pharmaceutical supplier and marketing division of Bridgewest Perth Pharma announce new production of Oral Morphine to meet cr...

 May 31, 2024 | News

Monash University and Thermo Fisher Scientific Forge New Partnership to Propel Scientific Advancements

Marking an exciting new chapter in a long-standing relationship, Monash University has entered into a Memorandum of Understanding with Thermo Fisher Scient...

 May 30, 2024 | News

SK Telecom Launches AI-Based Veterinary X-Ray Service 'X Caliber' in Australia

In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world ...

 May 29, 2024 | News

Neuren Pharmaceuticals Announces Positive Phase 2 Trial Results for NNZ-2591 in Pitt Hopkins Syndrome

Neuren Pharmaceuticals revealed top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS). This trial demo...

 May 28, 2024 | News

Telix Pharmaceuticals Submits NDA for Innovative Prostate Cancer Imaging Kit to FDA

Telix Pharmaceuticals  announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA...

 May 27, 2024 | News

Envac Wins €10 Million Contracts to Enhance Waste Management in French Hospitals

Smart waste management in hospitals has been increasingly important for achieving the higher standards of safety and environmental expectation required by ...

 May 22, 2024 | News

BeiGene and Glenmark Forge Strategic Partnership to Distribute Innovative Cancer Treatments in India

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced a new partnership with Glenmark Specialty S.A. (Glen...

 May 21, 2024 | News

Telix Pharmaceuticals' CUPID Study Demonstrates Promising Results for Next-Generation Prostate Cancer Therapy

CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer. Establishes ...

 May 21, 2024 | News

Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

    “Approval of the Axonics recharge-free system is welcome news for Australians with bladder and bowel dysfunction,” said...

 May 17, 2024 | News

NeuShen Therapeutics Begins Phase I Trial of NS-136, a Potential Breakthrough in Schizophrenia Treatment

NeuShen Therapeutics , a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today a...

 May 10, 2024 | News

Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open ...

 May 08, 2024 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in